Tower Research Capital (TRC)’s Creative Medical Technology CELZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73K | Sell |
1,029
-2,123
| -67% | -$5.63K | ﹤0.01% | 4602 |
|
|
2025
Q1 | $6.84K | Buy |
3,152
+1,504
| +91% | +$3.26K | ﹤0.01% | 4004 |
|
|
2024
Q4 | $3.81K | Buy |
1,648
+245
| +17% | +$566 | ﹤0.01% | 4588 |
|
|
2024
Q3 | $4.35K | Sell |
1,403
-696
| -33% | -$2.16K | ﹤0.01% | 4577 |
|
|
2024
Q2 | $8.08K | Buy |
2,099
+415
| +25% | +$1.6K | ﹤0.01% | 4399 |
|
|
2024
Q1 | $8.77K | Buy |
1,684
+781
| +86% | +$4.07K | ﹤0.01% | 3965 |
|
|
2023
Q4 | $4.16K | Sell |
903
-521
| -37% | -$2.4K | ﹤0.01% | 4987 |
|
|
2023
Q3 | $7.01K | Sell |
1,424
-629
| -31% | -$3.1K | ﹤0.01% | 4521 |
|
|
2023
Q2 | $9.52K | Buy |
2,053
+1,130
| +122% | +$5.24K | ﹤0.01% | 4245 |
|
|
2023
Q1 | $5K | Hold |
923
| – | – | ﹤0.01% | 4939 |
|
|
2022
Q4 | $4K | Sell |
923
-26
| -3% | -$113 | ﹤0.01% | 4988 |
|
|
2022
Q3 | $4K | Sell |
949
-6
| -0.6% | -$25 | ﹤0.01% | 5232 |
|
|
2022
Q2 | $7K | Buy |
955
+251
| +36% | +$1.84K | ﹤0.01% | 4767 |
|
|
2022
Q1 | $28K | Buy |
+704
| New | +$28K | ﹤0.01% | 3214 |
|